BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15988245)

  • 1. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.
    Borodic G; Bartley M; Slattery W; Glasscock M; Johnson E; Malazio C; Goodnough M; Acquadro M; McKenna M
    Plast Reconstr Surg; 2005 Jul; 116(1):36-43. PubMed ID: 15988245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
    Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
    Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
    Ondo WG; Simmons JH; Shahid MH; Hashem V; Hunter C; Jankovic J
    Neurology; 2018 Feb; 90(7):e559-e564. PubMed ID: 29343468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome.
    Bran GM; Börjesson PKE; Boahene KD; Gosepath J; Lohuis PJFM
    Plast Reconstr Surg; 2014 Jan; 133(1):121-129. PubMed ID: 24105091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
    Terzis JK; Karypidis D
    J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
    Hjelm N; Crippen M; Azizzadeh B
    Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox).
    Couch SM; Chundury RV; Holds JB
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):246-50. PubMed ID: 24807539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facing depression with botulinum toxin: a randomized controlled trial.
    Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
    J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of synkinesis.
    Husseman J; Mehta RP
    Facial Plast Surg; 2008 May; 24(2):242-9. PubMed ID: 18470836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenomenon of the late recovered Bell's palsy: treatment options to improve facial symmetry.
    Bulstrode NW; Harrison DH
    Plast Reconstr Surg; 2005 May; 115(6):1466-71. PubMed ID: 15861048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
    Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
    Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study.
    Placzek R; Drescher W; Deuretzbacher G; Hempfing A; Meiss AL
    J Bone Joint Surg Am; 2007 Feb; 89(2):255-60. PubMed ID: 17272437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
    Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.